<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="app1table3" position="float"><object-id pub-id-type="doi">10.7554/eLife.38200.022</object-id><label>Appendix 1&#8212;table 3.</label><caption><title>Mutations in <italic>rpoB</italic>, <italic>rpoA</italic> and <italic>rpoC</italic> associated with a putative compensatory effect in rifampicin resistant MTBC strains.</title><p>Data from 277 MDR-MTBC isolates from Karakalpakstan, Uzbekistan, stratified to the particularly successful variant termed Central Asian outbreak (CAO) and other Beijing isolates. Pairwise differences between the two groups calculated with Fisher exact test; two-tailed <italic>P</italic>-values are reported.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Beijing CAO <break/>(n&#160;=&#160;173)</th><th>Other Beijing <break/>(n&#160;=&#160;64)</th><th valign="top"><italic>P</italic>-value</th><th>All <break/>(n&#160;=&#160;277)</th></tr></thead><tbody><tr><td><italic>rpoB</italic> mutations outside RRDR, excluding codon 170,400,491 variants <break/>wild type</td><td>25 (14.5%) <break/>147 (85.0%)</td><td>12 (18.8%) <break/>52 (81.3%)</td><td valign="top">0.43</td><td>43 (15.5%) <break/>234 (84.5%)</td></tr><tr><td><italic>rpoC</italic> variants <break/>wild type</td><td>95 (54.9%) <break/>78 (45.1%)</td><td>18 (28.1%) <break/>46 (71.2%)</td><td valign="top">0.0002</td><td>126 (45.5%) <break/>151 (54.5%)</td></tr><tr><td><italic>rpoA</italic> variants <break/>wild type</td><td>5 (2.9%) <break/>168 (97.1%)</td><td>2 (3.1%) <break/>62 (96.9%)</td><td valign="top">1.00</td><td>7 (2.5%) <break/>270 (97.5%)</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: CAO&#160;=&#160;Central Asian outbreak, RRDR&#160;=&#160;rifampicin resistance determining region</p></fn></table-wrap-foot></table-wrap>